Updated treatment algorithm of pulmonary arterial hypertension.
about
Exercise-based rehabilitation programmes for pulmonary hypertensionGuanylate cyclase stimulators for pulmonary hypertensionGuanylate cyclase stimulators for pulmonary hypertensionInsight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of ViewDepression in pulmonary arterial hypertension: An undertreated comorbidityChallenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsThe limits of oral therapy in pulmonary arterial hypertension managementLeft ventricular heart failure and pulmonary hypertensionMedical treatment update on pulmonary arterial hypertensionPulmonary hypertension: diagnostic and therapeutic challengesThe molecular targets of approved treatments for pulmonary arterial hypertensionClinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanInterdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsSchistosomiasis-associated pulmonary hypertensionOptimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment courseThe clinical significance of antiphospholipid antibodies in systemic lupus erythematosusSelexipag in the treatment of pulmonary arterial hypertension: design, development, and therapyBreaking Down the Barriers: Why the Delay in Referral for Pulmonary Arterial Hypertension?Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertensionExercise-based rehabilitation programmes for pulmonary hypertension.Pulmonary Hypertension in Children.World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension.Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension.Consecutive Sessions of Rescue Balloon Atrial Septostomy for an Idiopathic Pulmonary Arterial Hypertension Patient with Refractory Right Heart Failure - Usefulness of Intracardiac Echocardiography Guidance.Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension.The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension.A systematic review of transition studies of pulmonary arterial hypertension specific medicationsClinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review.Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Challenges in managing pulmonary hypertension in the developing countries.Epidemiology and clinical impact of major comorbidities in patients with COPD.Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts.Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.Building the case for novel clinical trials in pulmonary arterial hypertensionConnective tissue disease-associated pulmonary arterial hypertension.Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study
P2860
Q24193326-29AF5D06-DD0D-45C4-84B4-5A37FD52B332Q24195067-D71618A5-AB76-4F38-9393-D6C591328429Q26470534-067C9F0E-739E-46F2-9FFE-6151022FB5FEQ26749283-E2D3278B-E549-470A-B819-5D34D24CC5A0Q26765107-91803B77-1ACC-4AB6-B124-20858F936C93Q26766294-64D8582D-3265-4060-897F-D4973E00A1E7Q26773209-8F735AD5-63F0-4D2D-AF4C-0D283873C63CQ26778341-BE75FCD7-5492-4EB2-A1D2-49328A21331CQ26785995-85E79319-4E89-45F0-BF0A-ADA3C7CF1A70Q26796434-3ED2A7AD-F803-48B6-AF66-4A24BE4FABAEQ26798308-EAA93668-2917-4FF2-8388-170ED0594ABBQ26851546-D0FE9A79-8448-442A-BF7D-B3D8DC516A15Q26860314-170896A7-4083-4069-94BD-A4D6052FED6BQ27006491-DD692C96-EB1D-4EDD-A65A-E586BC1B46F6Q27023074-C735BF9C-7CBF-454B-A0B9-39F596951A10Q28072610-1B213754-6FBC-4BC7-A10B-A559E30B3AACQ28072649-72173B99-A693-4DD1-903A-94ECEF98E200Q28078660-8AEB7B15-BE4E-476F-94B6-7DB0C1213BD1Q28083099-01126FAA-0D7B-49AC-B0E3-4AEE5D258E5FQ30238951-5822F2F1-ADDA-4813-8220-BF4CAAC23B63Q30248871-5CBA02C6-DE4D-4F54-B3B1-2C01EB43097DQ30248878-9413A37B-83F2-4326-90F7-EBA8320FDB1FQ32884516-7FB419E1-2A61-4063-8F08-6A52C8F37D3CQ33165207-4D7A4AC1-4495-41E7-87FB-E3D22292E36AQ33418891-F4E6F341-CF42-4C84-8CAD-AC58E232475FQ33440512-ED3C6BC0-A875-4175-B6B1-3706C3D8758CQ33729879-583189CA-82FA-406B-AF51-4F8CB17B575FQ33737242-66780959-7C4B-4340-B989-B119F16185B9Q33788447-E0AB7E8D-36A8-496E-A097-C7E444A94FCBQ33788548-4A005B55-A4BC-4584-BADC-D62E621935C1Q33816571-50156FDC-6F66-4305-A908-51D69605E60DQ33839496-23CA78EC-18FF-4734-8167-286632C21BC9Q33965891-1DC369D8-CFF2-4B36-AB68-41F0670D9F6CQ34134841-70C49A02-6845-4651-8401-0C64444038A4Q34444990-5B250E2B-B94E-4A98-9DF5-809E9156FB10Q34782476-A2EEC4C9-7CCE-4813-A4B5-A5220B557268Q34993093-34A828AC-62AE-44B8-9214-FC32782A6768Q35005853-216E0C07-B6A5-4BBF-B416-5BB734BFDC29Q35029607-2B02750A-4CF9-4416-9829-86B5B4FCFBBFQ35041528-C4C36B5C-0CAD-49C0-A9F0-A651B52E26A9
P2860
Updated treatment algorithm of pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Updated treatment algorithm of pulmonary arterial hypertension.
@en
type
label
Updated treatment algorithm of pulmonary arterial hypertension.
@en
prefLabel
Updated treatment algorithm of pulmonary arterial hypertension.
@en
P2093
P1476
Updated treatment algorithm of pulmonary arterial hypertension
@en
P2093
Adaani Frost
Anne Keogh
Ioana R Preston
John Granton
Julio Sandoval
Lewis J Rubin
Michael D McGoon
Paul A Corris
Reda E Girgis
Vallerie V McLaughlin
P304
P356
10.1016/J.JACC.2013.10.031
P407
P433
P577
2013-12-01T00:00:00Z